LOAD MORE
You're viewed all 12 products
The risks of Brimonidine impurities can include decreased efficacy, increased toxicity, and harm to patients' safety and health.
Impurities in Brimonidine affect the drug bioavailability by interfering with drug absorption or metabolism, leading to decreased efficacy or toxicity.
Impurities in Brimonidine are detected through various analytical techniques, such as HPLC and LC-MS.
Brimonidine impurities are stored at a controlled room temperature between 2-8 ⁰C or as indicated on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.